Nerve stimulation boosts hand therapy in infants with brain injury?
NCT ID NCT07063446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining a mild nerve stimulation (taVNS) with intensive hand therapy (CIMT) can improve arm function in infants aged 8-24 months who have one-sided weakness due to brain injury. Ten infants will receive 40 hours of therapy over two weeks, and researchers will also use brain stimulation to see which babies might benefit most. The goal is to help babies use their weaker hand better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcutaneous auricular vagus nerve stimulation (taVNS) paired with constraint-induced movement therapy (CIMT)
What this could lead to
If it works, this could point toward a new way to improve hand and arm function in infants with one-sided weakness after brain injury.
What could go wrong
This is a very small early study with only 10 infants, so results may not apply to all children. The treatment requires many hours of therapy, and it's unknown if the benefits will last.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMIPLEGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••